Quadria Capital, an Asia healthcare-focused private equity firm, has successfully raised $1.07 billion for its third fund, surpassing its i...

In this pre-IPO round, Quadria will acquire the minority stake in Aragen, at an approximate valuation of $1.4 bn, primarily through a fresh...

Quadria Capital is set to acquire a 10% stake in Aragen Life Sciences for about $100 million, valuing the Indian CRDMO at $1.2 billion. The...

Western Carriers' IPO has been subscribed 13.88 times, driven by strong demand from retail and non-institutional investors. The company pla...

Arkade Developers' IPO has been oversubscribed 30.2 times. Analysts recommend subscribing due to the company's strategic positioning in Mum...

Bajaj Finance shares rallied post-IPO but faced pressure today, declining 2%. Analysts recommend waiting for a price correction before buyi...

Investors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a minority stake and ...

ChrysCapital's proposed investment will give an exit to Mahindra Partners, the PE arm of Mahindra & Mahindra, which owns about 32% stake in...

Aragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platform...

The other contenders included Carlyle Group, Warburg Pincus, General Atlantic and Quadria Capital, as well as Singapore’s Temasek Holdings.

In this proposed transaction, GVK BIO- promoted by the GVK Group and DS Brar, the former CEO and managing director of Ranbaxy Laboratories,...

GVK Biosciences proposes to set up active pharmaceutical ingredients (APIs) manufacturing facility to cater to the needs of its existing an...